{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:38:01Z","timestamp":1789472281144,"version":"build-2803163510"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004916","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado do Amazonas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004916","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"\n Background<\/jats:title>\n Evidence on the optimal time to initiate antiretroviral therapy (ART) in the presence of toxoplasmic encephalitis (TE) is scarce. We compared the impact of early vs. delayed ART initiation on mortality and neurologic complications at discharge in a Brazilian population co-infected with HIV and TE.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We retrospectively evaluated data from 9 years of hospitalizations at a referral center in Manaus, Amazonas. All ART-na\u00efve hospitalized patients were divided into early initiation treatment (EIT) (0-4 weeks) and delayed initiation treatment (DIT) (&gt;4 weeks). The groups were compared using chi-square test and mortality at 16 weeks.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Four hundred sixty nine patients were included, of whom 357 (76.1%) belonged to the EIT group. The median CD4\n +<\/jats:sup>\n lymphocyte count and CD4\n +<\/jats:sup>\n \/CD8\n +<\/jats:sup>\n ratio were 53 cells\/mm\n 3<\/jats:sup>\n and 0.09, respectively. Mortality rate and presence of sequelae were 4.9% (\n n<\/jats:italic>\n = 23) and 41.6% (\n n<\/jats:italic>\n = 195), respectively. Mortality was similar between groups (\n p<\/jats:italic>\n = 0.18), although the EIT group had the highest prevalence of sequelae at discharge (\n p<\/jats:italic>\n = 0.04). The hazard ratio for death at 16 weeks with DIT was 2.3 (\n p<\/jats:italic>\n = 0.18). The necessity for intensive care unit admission, mechanical ventilation, and cardiopulmonary resuscitation were similar between groups.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n In patients with AIDS and TE, early ART initiation might have a detrimental influence on the occurrence of sequelae.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fmed.2022.759091","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T01:33:38Z","timestamp":1645752818000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Early Antiretroviral Therapy in AIDS Patients Presenting With Toxoplasma gondii Encephalitis Is Associated With More Sequelae but Not Increased Mortality"],"prefix":"10.3389","volume":"9","author":[{"given":"Nadia","family":"Cubas-Vega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"L\u00f3pez Del-Tejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djane C.","family":"Baia-da-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanderson Souza","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Ara\u00fajo","family":"Jardim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique Freire","family":"Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Carlos","family":"Lima Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izabella Picinin","family":"Safe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia A. Ara\u00fajo","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus Vin\u00edcius Guimar\u00e3es","family":"Lacerda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuelton Marcelo","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Val","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1371\/journal.pone.0098666","article-title":"Trends in AIDS-defining opportunistic illnesses incidence over 25 years in Rio de Janeiro, Brazil","author":"Coelho","year":"2014","journal-title":"PLoS ONE"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1016\/j.clineuro.2012.12.018","article-title":"Epidemiology and trend of neurological diseases associated to HIV\/AIDS. Experience of Mexican patients 1995-2009","volume":"115","author":"Ram\u00edrez-Crescencio","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/cid\/ciu191","article-title":"Molecular diagnosis of central nervous system opportunistic infections in HIV-infected Zambian adults","volume":"58","author":"Siddiqi","year":"2014","journal-title":"Clin Infect Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1212\/WNL.0b013e3182704040","article-title":"Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis","volume":"79","author":"Sonneville","year":"2012","journal-title":"Neurology."},{"key":"B5","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jinf.2017.05.018","article-title":"Incidence, presentation and outcome of toxoplasmosis in HIV infected in the combination antiretroviral therapy era","volume":"75","author":"Martin-Iguacel","year":"2017","journal-title":"J Infect."},{"key":"B6","first-page":"412","article-title":"Departamento de Vigil\u00e2ncia, Preven\u00e7\u00e3o e Controle das Infec\u00e7\u00f5es Sexualmente Transmis\u00edveis, do HIV\/Aids e das Hepatites Virais","year":"2018"},{"key":"B7","first-page":"464","volume-title":"UNAIDS Data 2021","year":"2021"},{"key":"B8","first-page":"67","article-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade","volume-title":"Boletim Epidemiol\u00f3gico HIV\/Aids | 2020","year":"2020"},{"key":"B9","unstructured":"Brasilia2019"},{"key":"B10","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.bjid.2012.10.030","article-title":"AIDS-related cerebral toxoplasmosis in S\u00e3o Paulo State, Brazil: Marked improvements in the highly active antiretroviral therapy-era but the challenges continue","volume":"17","author":"Vidal","year":"2013","journal-title":"Brazilian J Infect Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.clineuro.2016.08.014","article-title":"Cerebral toxoplasmosis in patients with acquired immune deficiency syndrome in the neurological emergency department of a tertiary hospital","volume":"150","author":"de Oliveira","year":"2016","journal-title":"Clin Neurol Neurosurg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e5575","DOI":"10.1371\/journal.pone.0005575","article-title":"Early antiretroviral therapy reduces AIDS progression\/death in individuals with acute opportunistic infections: A multicenter randomized strategy trial","volume":"4","author":"Zolopa","year":"2009","journal-title":"PLoS ONE"},{"key":"B13","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1469-0691.2012.03991.x","article-title":"Optimal timing for initiation of highly active antiretroviral therapy in treatment-na\u00efve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS cohort","volume":"19","author":"Manzardo","year":"2013","journal-title":"Clin Microbiol Infect."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0153921","article-title":"Time to HAART initiation after diagnosis and treatment of opportunistic infections in patients with AIDS in Latin America","volume":"11","author":"Crabtree-Ram\u00edrez","year":"2016","journal-title":"PLoS ONE."},{"key":"B15","volume-title":"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","year":"2021"},{"key":"B16","first-page":"1","volume-title":"Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy.","year":"2017"},{"key":"B17","first-page":"248","article-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade Departamento de Doen\u00e7as de Condi\u00e7\u00f5es Cr\u00f4nicas e Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis","volume-title":"Protocolo cl\u00ednico e diretrizes terapeuticas para aten\u00e7\u00e3o \u00e0s pessoas com infec\u00e7\u00f5es sexualmente transmiss\u00edveis","year":"2020"},{"key":"B18","first-page":"146","article-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade Departamento de Vigil\u00e2ncia, Preven\u00e7\u00e3o e Controle das Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis, do HIV\/Aids e das Hepatites Virais","volume-title":"Manual T\u00e9cnico Para o Diagn\u00f3stico Da Infec\u00e7\u00e3o Pelo HIV Em Adultos e Crian\u00e7as","year":"2018"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2325958219867315","article-title":"HIV-Related cerebral toxoplasmosis revisited: Current concepts and controversies of an old Disease","volume":"18","author":"Vidal","year":"2019","journal-title":"J Int Assoc Provid AIDS Care."},{"key":"B20","first-page":"186","volume-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de DST A e HV. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas para Manejo da Infec\u00e7\u00e3o pelo HIV em Adultos","year":"2013"},{"key":"B21","first-page":"1","volume-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade: Recomenda\u00e7\u00f5es para Terapia Anti\u2013retroviral em Adultos Infectados pelo HIV: 2008.","year":"2008"},{"key":"B22","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S2468-2667(16)30020-2","article-title":"Mortality and causes of death in people diagnosed with HIV in the era of highly active antiretroviral therapy compared with the general population: an analysis of a national observational cohort","volume":"2","author":"Croxford","year":"2017","journal-title":"Lancet Public Heal."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12981-019-0250-2","article-title":"Immediate versus deferred antiretroviral therapy in HIV-infected patients presenting with acute AIDS-defining events (toxoplasmosis, Pneumocystis jirovecii-pneumonia): a prospective, randomized, open-label multicenter study (IDEAL-study)","volume":"16","author":"Sch\u00e4fer","year":"2019","journal-title":"AIDS Res Ther."},{"key":"B24","doi-asserted-by":"publisher","first-page":"32","DOI":"10.7326\/M14-2979","article-title":"Optimal timing of antiretroviral therapy initiation for HIV-infected adults with newly diagnosed pulmonary tuberculosis: A systematic review and meta-analysis","volume":"163","author":"Uthman","year":"2015","journal-title":"Ann Intern Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s12192-017-0815-8","article-title":"The reality of scientific research in Latin America) an insider's perspective","volume":"22","author":"Ciocca","year":"2017","journal-title":"Cell Stress Chaperones."},{"key":"B26","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.molmed.2016.06.013","article-title":"Challenges for scientists in Latin America","volume":"22","author":"Kalergis","year":"2016","journal-title":"Trends Mol Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.11604\/pamj.2019.32.67.17580","article-title":"The HIV\/AIDS pandemic will not end by the year 2030 in low and middle income countries","volume":"32","author":"Bain","year":"2019","journal-title":"Pan Afr Med J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0007962","article-title":"Central Latin America: Two decades of challenges in neglected tropical disease control","volume":"14","author":"Hotez","year":"2020","journal-title":"PLoS Negl Trop Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s40588-015-0024-0","article-title":"Neurological and Neuropsychiatric consequences of chronic Toxoplasma infection","volume":"2","author":"Flegr","year":"2015","journal-title":"Curr Clin Microbiol Reports."},{"key":"B30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrneurol.2016.149","article-title":"HIV-associated opportunistic CNS infections: Pathophysiology, diagnosis and treatment","volume":"12","author":"Bowen","year":"2016","journal-title":"Nat Rev Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/nrneurol.2017.120","article-title":"Tuberculous meningitis","volume":"13","author":"Wilkinson","year":"2017","journal-title":"Nat Rev Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.22374\/1710-6222.26.1.1","article-title":"Clinically significant drug-drug interaction in a large antiretroviral treatment centre in Lagos, Nigeria","volume":"26","author":"Oreagba","year":"2019","journal-title":"J Popul Ther Clin Pharmacol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/jcph.978","article-title":"Addressing antiretroviral therapy-associated drug-drug interactions in patients requiring treatment for opportunistic infections in low-income and resource-limited settings","volume":"57","author":"Chastain","year":"2017","journal-title":"J Clin Pharmacol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15284336.2017.1404690","article-title":"Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team","volume":"19","author":"Molas","year":"2018","journal-title":"HIV Clin Trials."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.2147\/TCRM.S175704","article-title":"Comparative study of antiretroviral drug regimens and drug\u2013drug interactions between younger and older HIV-infected patients at a tertiary care teaching hospital in South Korea","volume":"14","author":"Park","year":"2018","journal-title":"Ther Clin Risk Manag."},{"key":"B36","first-page":"464","volume-title":"Hist\u00f3rias da Aids no Brasil, 1983-2003: as respostas governamentais \u00e0 epidemia de aids","author":"Laurindo-Teodorescu","year":"2015"},{"key":"B37","article-title":"Departamento de Vigil\u00e2ncia Preven\u00e7\u00e3o e Controle das Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis do HIV\/Aids e das Hepatites Virais","volume-title":"Nota Informativa no 03\/18 - COVIG\/CGVP\/.DIAHV\/SVS\/MS: switch de esquemas com ITRNN e IP\/r por DTG","year":"2018"},{"key":"B38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1590\/S0037-86822008000300005","article-title":"Causas de \u00f3bito em pacientes com s\u00edndrome da imunodefici\u00eancia adquirida, necropsiados na Funda\u00e7\u00e3o de Medicina Tropical do Amazonas","volume":"41","author":"De Souza","year":"2008","journal-title":"Rev Soc Bras Med Trop."},{"key":"B39","first-page":"71","article-title":"Boletim Epidemiol\u00f3gico HIV\/ Aids | 2019","year":"2019"},{"key":"B40","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1093\/aje\/kwz252","article-title":"The population impact of late presentation with advanced HIV disease and delayed antiretroviral therapy in adults receiving HIV care in Latin America","volume":"189","author":"Belaunzar\u00e1n-Zamudio","year":"2019","journal-title":"Am J Epidemiol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1111\/hiv.12045","article-title":"Ten-year mortality trends among persons diagnosed with HIV infection in England and Wales in the era of antiretroviral therapy: AIDS remains a silent killer","volume":"14","author":"Simmons","year":"2013","journal-title":"HIV Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1080\/13803390701819036","article-title":"An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults","volume":"30","author":"Levine","year":"2008","journal-title":"J Clin Exp Neuropsychol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/23259582211043863","article-title":"Nijhawan A. Toxoplasmosis encephalitis: a cross-sectional analysis at a US safety-net hospital in the late cART era","volume":"20","author":"Lau","year":"2021","journal-title":"J Int Assoc Provid AIDS Care."},{"key":"B44","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1089\/apc.2005.19.626","article-title":"Cerebral toxoplasmosis in HIV-positive patients in Brazil: Clinical features and predictors of treatment response in the HAART era","volume":"19","author":"Vidal","year":"2005","journal-title":"AIDS Patient Care STDS."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1086\/424877","article-title":"Prevalence, associated factors, and prognostic determinants of AIDS-related toxoplasmic encephalitis in the era of advanced highly active antiretroviral therapy","volume":"39","author":"Antinori","year":"2004","journal-title":"Clin Infect Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1007\/s10096-017-2973-0","article-title":"The burden and epidemiology of community-acquired central nervous system infections: a multinational study","volume":"36","author":"Erdem","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/cid\/cis899","article-title":"Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome","volume":"56","author":"Marais","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1177\/0956462414563630","article-title":"Cryptococcal meningoencephalitis relapse after an eight-year delay: an interplay of infection and immune reconstitution","volume":"26","author":"Katchanov","year":"2015","journal-title":"Int J STD AIDS."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1097\/QAD.0000000000001492","article-title":"Immune reconstitution inflammatory syndrome associated with toxoplasmic encephalitis in HIV-infected patients","volume":"31","author":"Van Bilsen","year":"2017","journal-title":"Aids"},{"key":"B50","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/jnnp.2009.199919","article-title":"Toxoplasmic encephalitis IRIS in HIV-infected patients: A case series and review of the literature","volume":"82","author":"Martin-Blondel","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B51","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis","volume":"370","author":"Boulware","year":"2014","journal-title":"N Engl J Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1371\/journal.pone.0011416","article-title":"Risk factor analyses for immune reconstitution inflammatory syndrome in a randomized study of early vs. deferred ART during an opportunistic infection","volume":"5","author":"Grant","year":"2010","journal-title":"PLoS ONE."},{"key":"B53","doi-asserted-by":"publisher","first-page":"e21141","DOI":"10.1097\/MD.0000000000021141","article-title":"A study for precision diagnosing and treatment strategies in difficult-to-treat AIDS cases and HIV-infected patients with highly fatal or highly disabling opportunistic infections: study protocol for antiretroviral therapy timing in AIDS patients with tox","volume":"99","author":"Zeng","year":"2020","journal-title":"Medicine (Baltimore)."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.759091\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T01:33:45Z","timestamp":1645752825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.759091\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":53,"alternative-id":["10.3389\/fmed.2022.759091"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.759091","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,25]]},"article-number":"759091"}}